You can find the annual or quarterly income statement of Eikon Therapeutics Ord Shs here for insights into the performance and operational efficiency of Eikon Therapeutics Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

Operating expenses

--87.34M

--83.17M

R&D expenses

--70.05M

--65.23M

Depreciation, depletion, and amortization

--5.21M

--5.40M

Operating profit

---87.34M

---83.17M

Net non-operating interest income (expenses)

Non-operating interest income

----

--3.52M

Other non-operating income (expenses)

---1.00K

---9.00K

Income before tax

----

---79.66M

Income after tax

----

---79.66M

Net income from continuous operations

---82.96M

---79.66M

Net income attributable to controlling interests

---82.96M

---79.66M

Net income attributable to common shareholders

---82.96M

---79.66M

Basic earnings per share

---2.46

---1.48

Diluted earnings per share

---2.46

---1.48

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

